uric acid has been researched along with Adrenal Hyperplasia, Congenital in 3 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Adrenal Hyperplasia, Congenital: A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied 12 women with NC-CAH, 6 of whom because of coexisting hypercholesterolemia received atorvastatin (20-40 mg daily)." | 7.91 | The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study. ( Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B, 2019) |
| "Uric acid values were lower in WC compared with the PC group (p < 0." | 5.39 | [Elevated levels of leptin and LDL-cholesterol in patients with well controlled congenital adrenal hyperplasia]. ( Faria, JA; Lago, R; Nunes-Silva, D; Oliveira, LM; Toralles, MB, 2013) |
| "We studied 12 women with NC-CAH, 6 of whom because of coexisting hypercholesterolemia received atorvastatin (20-40 mg daily)." | 3.91 | The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study. ( Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B, 2019) |
| "Uric acid values were lower in WC compared with the PC group (p < 0." | 1.39 | [Elevated levels of leptin and LDL-cholesterol in patients with well controlled congenital adrenal hyperplasia]. ( Faria, JA; Lago, R; Nunes-Silva, D; Oliveira, LM; Toralles, MB, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Krysiak, R | 2 |
| Kowalcze, K | 2 |
| Marek, B | 1 |
| Okopień, B | 2 |
| Bednarska-Czerwińska, A | 1 |
| Oliveira, LM | 1 |
| Faria, JA | 1 |
| Nunes-Silva, D | 1 |
| Lago, R | 1 |
| Toralles, MB | 1 |
3 other studies available for uric acid and Adrenal Hyperplasia, Congenital
| Article | Year |
|---|---|
Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adult; Biomarkers; C-Reactive Protein; Cardiometabolic Risk Factors | 2020 |
The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Atorvastatin; C-Reactive Protein; Cardiovascular | 2019 |
[Elevated levels of leptin and LDL-cholesterol in patients with well controlled congenital adrenal hyperplasia].
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Body Mass Index; Child; Child, Preschool; Choles | 2013 |